منابع مشابه
Monte Carlo calculations of dose distribution for the treatment of gastric cancer with proton therapy
Proton therapy is a common form of external radiation therapy based on the manipulation of Bragg peak of this beam, it can treat the tumor by delivering high levels of doses to it, while protecting surrounding healthy tissues against radiation. In this work, the dose distribution of proton and secondary particles such as neutrons, photons, electrons and positrons in gastric cancer proton therap...
متن کاملProton Therapy for Prostate Cancer - Cancer Network
Proton therapy has been used in the treatment of cancer for over 50 years. Due to its unique dose distribution with its spread-out Bragg peak, proton therapy can deliver highly conformal radiation to cancers located adjacent to critical normal structures. One of the important applications of its use is in prostate cancer, since the prostate is located adjacent to the rectum and bladder. Over 30...
متن کاملInterventional Therapy for Pancreatic Cancer.
BACKGROUND Palliative therapy and primarily chemoradiotherapy are the mainstream treatments in patients with locally advanced or metastatic pancreatic cancer (PC). Conventional endoscopy and endoscopic ultrasound (EUS)-guided interventional therapy has emerged as an important procedure for PC management. In this review, the progress in conventional endoscopy and EUS for PC management is discuss...
متن کاملVaccine therapy for pancreatic cancer
Pancreatic cancer is a lethal disease and currently available therapies have significant limitations. Pancreatic cancer is thus an ideal setting for the development of novel treatment modalities such as immunotherapy. However, relevant obstacles must be overcome for immunotherapeutic regimens against pancreatic cancer to be successful. Vaccine therapy relies on the administration of biological ...
متن کاملAdjuvant therapy for pancreatic cancer.
Survival for patients with pancreas cancer is correlated to stage. Only 20% of patients present with localized disease amenable to potentially curative resection but, despite resection, the 5-year survival rate for early stage patients remains less than 25%. Current accepted standard of care is adjuvant gemcitabine following curative resection but there have been no conclusions regarding the ro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Gastrointestinal Oncology
سال: 2015
ISSN: 1948-5204
DOI: 10.4251/wjgo.v7.i9.141